We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




When Exercise Is Unhealthy: Study Sheds New Light on Sudden Cardiac Death

By LabMedica International staff writers
Posted on 06 Dec 2015
Researchers have discovered new aspects, involving a mutated protein, of a not-well-understood mechanism that underlies how sudden heart failure can occur during endurance exercise in patients with arrhythmogenic ventricular cardiomyopathy (AVC), which currently has no standardized guidelines for exercise management. More...
The findings may inform development of early diagnostics, drug treatments, and personalized exercise programs.

AVC is the most common heart condition that causes sudden cardiac death during intense exercise. Using various analyses of cardiac function and morphology, a team led by Jeffrey A. Towbin, MD, of the University of Tennessee Health Science Center (Memphis, TN, USA), in collaboration with researchers from Cincinnati Children’s Hospital Medical Center (Cincinnati, OH, USA) and others has found that in mice with a known mutated version of desmoplakin, a protein that helps maintain the structure of the heart wall, exercise made the heart walls come apart sooner, leading to earlier development of AVC.

Heart wall cells are stacked in interlocking layers attached to each other by desmosomes that dot the surface of the cells. Exercise can overstretch the heart wall, but these intercellular links keep the cells from disconnecting from each other and prevent the heart wall from coming apart. Desmosomes are made up of several proteins, including desmoplakin. Defects can weaken the cell-cell links, as in AVC, such that the cells do not withstand the extra stretch from exercise and so detach from each other. Scar tissue fills the gaps between the disconnected cells, further reducing the wall’s ability to withstand increased workload as in exercise.

Several studies observed that mice with a mutated form of desmoplakin developed the same heart problems seen in patients with AVC. In this new study, in addition to finding that endurance exercise led to earlier onset of AVC symptoms in the mice with the mutated desmoplakin, the researchers also discovered that the desmosomes started coming apart before changes in heart function were detected and that exercise perturbed AKT1 and GSK3-β signaling in the Wnt-β-catenin pathway, which promotes growth of new cells and prevents deposition of fat, offering an explanation for the accelerated development of AVC.

The study suggests that changes in the cell-cell links can be detected before alterations in heart function occur. This could help identify individuals with the mutation before they develop AVC symptoms, said Dr. Towbin, opening the possibility of better strategies to prevent exercise-induced complications and of developing drugs targeting the Wnt-β-catenin pathway to potentially help AVC patients.

The study, by Martherus R et al., was published online ahead of print November 6, 2015, in the American Journal of Physiology — Heart & Circulatory Physiology.

Related Links:

University of Tennessee Health Science Center
Cincinnati Children’s Hospital Medical Center



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.